Versant Ventures V, LLC is > 10% Shareholder of Repare Therapeutics Inc.. Currently has a direct ownership of 0 shares of RPTX, which is worth approximately $0. The most recent transaction as insider was on Jun 06, 2022, when has been sold 141,103 shares (Common Shares) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
0% 12M change
Total Value Held $0

Versant Ventures V, LLC Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 06 2022
SELL
Other acquisition or disposition
-
141,103 Reduced 100.0%
0 Common Shares
Jun 06 2022
BUY
Other acquisition or disposition
-
141,103 Added 50.0%
141,103 Common Shares
May 05 2021
SELL
Other acquisition or disposition
-
48,528 Reduced 100.0%
0 Common Shares
May 05 2021
BUY
Other acquisition or disposition
-
48,528 Added 50.0%
48,528 Common Shares
Jan 29 2021
SELL
Other acquisition or disposition
-
60,472 Reduced 100.0%
0 Common Shares
Jan 29 2021
BUY
Other acquisition or disposition
-
60,472 Added 50.0%
60,472 Common Shares
Jan 14 2021
SELL
Other acquisition or disposition
-
35,276 Reduced 100.0%
0 Common Shares
Jan 14 2021
BUY
Other acquisition or disposition
-
35,276 Added 50.0%
35,276 Common Shares

Also insider at

TSBX
Turnstone Biologics Corp.
VVV

Versant Ventures V, LLC

> 10% Shareholder
San Francisco, CA

Track Institutional and Insider Activities on RPTX

Follow Repare Therapeutics Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RPTX shares.

Notify only if

Insider Trading

Get notified when an Repare Therapeutics Inc. insider buys or sells RPTX shares.

Notify only if

News

Receive news related to Repare Therapeutics Inc.

Track Activities on RPTX